Key result
Outpatient cardiology referrals carry a low ~3% long-term major cardiovascular events rate, enabling symptom-based risk stratification.
Why the study?
With an increasing burden of cardiovascular disease and rising demand for outpatient cardiology services, referral patterns from primary care and longer term clinical outcomes based on symptomatology and risk stratification needed evaluation.
Does risk stratification based on referral symptomatology predict long-term adverse clinical outcomes in stable outpatients referred to cardiology?
Cohort (n=33,244)
No
Does risk stratification based on referral symptomatology predict long-term adverse clinical outcomes in stable outpatients referred to cardiology?
Risk stratification of stable outpatients referred to cardiology can identify low-risk subsets with very low 3-year rates of mortality and MACE, potentially reducing the need for incremental testing.
Answers are grounded in this paper and cite their sources.
May support risk-based triage of low-risk referrals; extends pre-test probability models with real-world outcome data.
Introduction With an increasing burden of cardiovascular disease, there has been rising demands for outpatient cardiology services. In this study, we reviewed the cardiology referral patterns from primary care to a tertiary cardiac centre, and evaluated their longer term clinical outcomes based on referral symptomatology as well as risk stratification. Methods Consecutive outpatients referred from primary care to a national cardiac centre between March 2015 to December 2020 were included. Patients with known coronary artery disease (CAD) were excluded. Chest pain patients were stratified by pre-test probability (PTP) of obstructive CAD using chest pain risk scores and the rest by age and sex. Outcomes studied included mortality and major adverse cardiovascular events (MACE). Results A total of 33,244 patients (11,865 chest pain, 3427 palpitations, 2844 dyspnoea) were included. In patients with chest pain, the 3-year mortality and MACE rates were 1.25% and 3.19% respectively. Patients with higher PTP of CAD demonstrated significantly higher rates of adverse events. In patients with palpitations, the 3-year mortality and MACE rates were 0.86% and 1.55% respectively. Males aged >65years had significantly higher risk of 3-year mortality ( p < .00.5). In patients with dyspnoea, the 3-year mortality and MACE rates were 3.34 and 4.44% respectively. Subsets of younger age and/or female sex had lower rates of adverse events. Conclusions While long term adverse clinical outcomes were generally low in this stable outpatient cohort, risk stratification allowed for identification of an even lower risk subset of patients for whom additional testing may potentially not yield incremental clinical benefit.
No takes yet. Share an insight, caveat, or question.
Chua et al. (2025) conducted a cohort in Outpatient cardiology referrals (n=33,244). Cardiology referral for chest pain, palpitations, or dyspnoea was evaluated on Mortality and major adverse cardiovascular events (MACE). Among 33,244 outpatients referred to cardiology, 3-year mortality and major cardiovascular events rates were low, and risk stratification identified lower-risk subsets.
Synapse has enriched 10 related papers. Consider them for comparative context: